|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||

*
From the Division of Pulmonary and Critical Care Medicine (Dr. Baumann), University of Mississippi Medical Center, Jackson, MS; Division of Pulmonary and Critical Care Medicine (Drs. Strange and Sahn), Medical University of South Carolina (Dr. Heffner), Charleston, SC; Vanderbilt University (Dr. Light), Saint Thomas Hospital, Nashville, TN; Thoracic Surgery (Dr. Kirby); University Hospitals of Cleveland, Cleveland, OH; Department of Radiology (Dr. Klein), University of Vermont College of Medicine, Burlington, VT; Thoracic Surgery (Dr. Luketich), University of Pittsburgh Medical Center, Pittsburgh, PA;and Emergency Medicine (Dr. Panacek), University of California-Davis, Sacramento, CA.
A complete list of the consensus group is located in Appendix 1.
Correspondence to: Michael H. Baumann, MD, FCCP, Associate Professor of Medicine, Division of Pulmonary and Critical Care Medicine, University of Mississippi Medical Center, 2500 North State St, Jackson, MS 39216-4505; e-mail: mbaumann{at}medicine.umsmed.edu
| Abstract |
|---|
|
|
|---|
Options: Decisions for observation, chest tube placement, surgical interventions, and radiographic imaging.
Outcomes: Effectiveness of pneumothorax resolution, duration of and patient tolerance of care, and pneumothorax recurrence.
Evidence: Literature review from 1967 to January 1999 and Delphi questionnaire submitted in three iterations to a multidisciplinary physician panel.
Values: The guideline development group determined by consensus the relevant outcomes to be considered in developing the Delphi questionnaire.
Benefits, harms, and costs: The type and magnitude of benefits, harms, and costs expected for patients from guideline implementation.
Recommendations: Management decisions vary between patients with primary or secondary pneumothoraces, with observation of small pneumothoraces being appropriate only for primary pneumothoraces. The level of consensus varies regarding the specific interventions indicated, but agreement exists for the general principles of care.
Validation: Recommendations were peer reviewed by physician experts and were reviewed by the American College of Chest Physicians (ACCP) Health and Science Policy Committee.
Implementation: The guideline recommendations will be published in printed and electronic form with distribution of synopses for patients and health care providers. Contents of the guideline will be incorporated into continuing medical education programs.
Sponsors: The ACCP.
Key Words: consensus Delphi guideline management pneumothorax practice guideline spontaneous pneumothorax
| Introduction |
|---|
|
|
|---|
Although primary and secondary spontaneous pneumothoraces affect > 20,000 patients per year in the United States2 and account for nearly $130,000,000 in health-care expenditures each year,3 generally accepted and methodologically sound guidelines for the care of these patients do not exist. Consequently, observational studies demonstrate extensive practice variation in the management of this relatively common condition.4
To address this variation in care, the American College of Chest Physicians (ACCP) commissioned the development of a practice guideline for the management of spontaneous pneumothorax. The guideline committee recognized that insufficient data existed from randomized controlled trials to develop an evidence-based document and that recommendations would largely derive from expert opinion. Because informal approaches for developing expert-based statements are subject to extensive bias, the guideline developers selected the Delphi technique5 to formalize the expert panels consensus process and explicitly state opinion. The methodology for this consensus guideline provides clinicians with a description of the level of consensus achieved for each treatment recommendation and identifies clinical settings wherein multiple options for care exist. The guideline pertains to adult patients with primary spontaneous pneumothorax and patients with secondary pneumothorax associated with COPD. Many of the recommendations will have relevance to secondary pneumothoraces affecting patients with underlying lung disorders other than COPD.
| Materials and Methods |
|---|
|
|
|---|
|
The chairmen met with the project development committee to organize the Delphi process and to select members of the expert panel. Panel members were selected from specialty fields proportionally related to the distribution of publications on the management of pneumothorax among specialty and subspecialty journals. This proportionality was determined by a MEDLINE literature search from 1966 to 1997 (see below). Experts were eligible for selection if they had published a peer-reviewed article on pneumothorax during the previous 5 years. Each member provided a written statement disclosing the existence of any corporate relationships related to the care of patients with pneumothoraces. The distribution of panel members among medical specialties were as follows: pulmonary/critical care, 12 members (38%); thoracic surgery, 12 members (38%); general surgery, 1 member (3%); interventional radiology, 3 members (9%); and emergency medicine, 4 members (13%).
Literature Search
A MEDLINE literature search of English language articles was
performed for the period from 1966 to 1997. The MeSH heading of
spontaneous pneumothorax was combined with the terms randomized
controlled trials, meta-analysis, and
guidelines. Recent review articles were searched for
additional randomized controlled trials. Retrieved articles were
distributed to panel members. The literature search was repeated during
each of the three iterations of the Delphi questionnaire, with the last
literature search occurring in January 1999. Retrieved articles were
graded by the two content chairmen on the basis of the articles study
designs (Table 1 ).8
The methodology chairman resolved grading disagreements
with a majority vote.
|
Delphi Questionnaire
The guideline development committee met to design a
questionnaire that would query panel members about management decisions
in the care of patients with primary spontaneous pneumothoraces and
secondary pneumothoraces due to COPD. The committee constructed a
decision tree for the care of patients with pneumothoraces and selected
decision branch points for inclusion into the questionnaire that were
considered by the committee to be key management practices. The
committee did not discuss the appropriateness of these practices so as
to avoid influencing the questionnaire development or bias members in
attendance who would later respond to the questionnaire.
Most questions were case-based scenarios with multiple management options presented as choices (Fig 2 ). Panel members were asked to respond to the appropriateness of each option using a 9-point Likert scale (Table 2 ). A few questions were open-ended, multiple choice, or requested a "yes" or "no" response.
|
|
The questionnaire listed on its face page definitions of terms and clinical assumptions (Tables 3 , 4 ).
|
Summaries of item responses were placed adjacent to the specific item and were described as follows. The number of panel members responding to each item was listed. Bar and dot symbols were placed adjacent to the Likert scales to indicate median responses, middle 50% range, and the range for all responses. Similar summary statistics were presented for open-ended questions that requested a numeric response. A number reported the proportion of panel members responding "yes" or "no" to an item. Panel members were provided with a key for each questionnaire that explained the data summary techniques.
This second questionnaire was mailed to panel members. Responses to the second questionnaires items, the panel members comments, and cited literature were summarized and incorporated into a third questionnaire that was mailed to the panel members. Bar and dot symbols (Fig 2) were placed over the Likert scales to indicate median responses, the middle 50% range, the middle 80% range, and outlier responses. The third mailing included printed copies of the abstracts from the articles cited by panel members in support of their responses to specific questionnaire items.
Description of Level of Consensus and Degree of Evidence-Based
Support
Responses to the third questionnaires items that used the
9-point Likert scale were summarized and applied to a priori
definitions to determine levels of consensus (Table 5
). Evidence cited in the questionnaire by panel members to support their
questionnaire responses also was cited in the guideline text with an
evidence grade.
|
|
| Results and Management Recommendations |
|---|
|
|
|---|
|
Primary Spontaneous Pneumothorax
Clinically Stable Patients With Small Pneumothoraces:
Clinically stable patients with small pneumothoraces should be observed
in the emergency department for 3 to 6 h and discharged home if a
repeat cheat radiograph excludes progression of the pneumothorax (good
consensus). Patients should be provided with careful instructions for
follow-up within 12 h to 2 days, depending on circumstances. A
chest radiograph should be obtained at the follow-up appointment to
document resolution of the pneumothorax. Patients may be admitted for
observation if they live distant from emergency services or follow-up
care is considered unreliable (good consensus). Simple aspiration of
the pneumothorax or insertion of a chest tube is not appropriate for
most patients (good consensus), unless the pneumothorax enlarges. The
presence of symptoms for > 24 h does not alter the treatment
recommendations.
Clinically Stable Patients With Large Pneumothoraces:
Clinically stable patients with large pneumothoraces should undergo a
procedure to reexpand the lung and should be hospitalized in most
instances (very good consensus). The lung should be reexpanded by using
a small-bore catheter (
14F) or placement of a 16F to 22F chest tube
(good consensus). Catheters or tubes may be attached either to a
Heimlich valve (good consensus) or to a water seal device (good
consensus) and may be left in place until the lung expands against the
chest wall and air leaks have resolved. If the lung fails to reexpand
quickly, suction should be applied to a water-seal device.
Alternatively, suction may be applied immediately after chest tube
placement for all patients managed with a water seal system (some
consensus).
Reliable patients who are unwilling to undergo hospitalization may be discharged home from the emergency department with a small-bore catheter attached to a Heimlich valve if the lung has reexpanded after the removal of pleural air (good consensus). Follow-up should be arranged within 2 days. The presence of symptoms for > 24 h does not alter management recommendations.
Clinically Unstable Patients With Large Pneumothoraces:
Unstable patients with large pneumothoraces should undergo
hospitalization with insertion of a chest catheter to reexpand the lung
(very good consensus). Most patients should be treated with a 16F to
22F standard chest tube (good consensus) or with a small-bore catheter
(good consensus), depending on the degree of clinical instability. A
24F to 28F standard chest tube may be used if the patient is
anticipated to have a bronchopleural fistula with a large air leak or
requires positive-pressure ventilation (good consensus). A water seal
device can be used without suction initially (good consensus), but
suction should be applied if the lung fails to reexpand with water seal
drainage. Suction may be alternatively applied immediately after chest
tube placement (some consensus). Some patients may be managed with a
small-bore catheter attached to a Heimlich valve if clinical stability
can be obtained with immediate evacuation of the pleural space (good
consensus). A water seal device should be substituted for the Heimlich
valve and suction applied if the lung fails to reexpand (good
consensus).
Chest Tube Removal:
Chest tubes should be removed in a staged manner so as to ensure that
the air leak into the pleural space has resolved (good consensus). The
first stage requires that a chest radiograph demonstrates complete
resolution of the pneumothorax and that there is no clinical evidence
of an ongoing air leak. Any suction applied to the chest tube should be
discontinued (good consensus).
Fifty-three percent of panel members would never clamp a chest tube to
detect the presence of an air leak after reexpansion of the lung. The
remaining panel members would clamp the chest tube approximately 4
h after the last evidence of an air leak. Regardless of whether the
tube was or was not clamped, panel members would repeat a chest
radiograph 5 to 12 h after the last evidence of an air leak (62%
of members) to ensure that the pneumothorax had not reoccurred in
preparation for pulling the chest tube. Other panel members would wait
4 h (10%), 13 to 23 h (10%), or 24 h (17%) before
repeating a chest radiograph.
Persistent Air Leaks:
For patients with persistent air leaks, the panel recommended continued
observation for 4 days for spontaneous closure of bronchopleural
fistula (median, 4 days; interquartile range, 3 to 5 days; middle 80%
range, 2 to 6 days). Patients with air leaks persisting beyond 4 days
should be evaluated for surgery to close the air leak and to perform a
pleurodesis procedure to prevent pneumothorax recurrence (very good
consensus). Although the relative value of thoracoscopy compared to a
limited thoracotomy has not been clearly defined, the panel selected
thoracoscopy as the preferred management (very good consensus).
Patients should not undergo the placement of an additional chest tube
or bronchoscopy with attempts to seal endobronchial sites of air leaks
(very good consensus). Most patients should not be managed with
chemical pleurodesis by instilling sclerosing agents through the chest
tube except in special circumstances in which surgery is
contraindicated or patients refuse an operative procedure (very good
consensus). If chemical pleurodesis is performed, doxycycline or talc
slurry is the preferred sclerosing agent (good consensus).
Pneumothorax Recurrence Prevention:
Except for patients with persistent air leaks, procedures to prevent
the recurrence of a primary spontaneous pneumothorax should be reserved
for the second pneumothorax occurrence (85% of panel members). Fifteen
percent of panel members, however, would offer patients an intervention
to prevent a recurrence after the first pneumothorax. Patients
preferences and interests in continuing activities that would place
them at high risk if a pneumothorax reoccurred (eg,
scuba diving or flying) should be considered in deciding the timing of
the intervention. Thoracoscopy is the preferred intervention for
preventing pneumothorax recurrence (very good consensus). The
instillation of sclerosing agents through a chest tube is an acceptable
approach for pneumothorax prevention in patients who wish to avoid
surgery and for patients who present increased surgical risk
(eg, bleeding diathesis) (good consensus). Success rates
with chemical pleurodesis, however, are only 78 to 91% compared to
success rates of 95 to 100% with surgical interventions.3
Patients selected for surgical prevention of pneumothorax recurrence should be managed by thoracoscopy (very good consensus). The panel could not agree on the utility of limited (axillary) thoracotomy in recurrence prevention. The panel noted that clinical trials that include patients with primary spontaneous pneumothorax do not demonstrate the superiority of thoracoscopy vs limited thoracotomy in pneumothorax prevention12 21 ; the panels preference for thoracoscopy was based on practice preferences.
Thoracoscopy can be performed with or without video assistance. Patients with apical bullae visualized at surgery should undergo intraoperative bullectomy (very good consensus). Bullectomy should be performed by staple bullectomy (very good consensus). Options for eliminating bullae include electrocoagulation, laser ablation, or hand sewing, depending on institutional expertise and experience with these procedures. Intraoperative pleurodesis should be performed in most patients with parietal pleural abrasion limited to the upper half of the hemithorax (good consensus). Parietal pleurectomy (some consensus) is an acceptable alternative pleurodesis technique. No consensus was reached regarding the utility of talc poudrage in primary spontaneous pneumothorax recurrence prevention.
Chest Imaging With CT:
The panel did not recommend the routine use of chest CT imaging for
patients with a first-time pneumothorax (good consensus). The panel did
not achieve consensus regarding the utility of chest CT scans for
evaluating patients with recurrent pneumothoraces, persistent air
leaks, or planned surgical interventions. Chest CT may be indicated to
evaluate the presence of pulmonary disorders, such as interstitial lung
disease, that are suspected clinically but are not apparent on standard
radiographs.
Age Considerations:
The questionnaire did not query the panel regarding the importance of
age in making management decisions.
Secondary Spontaneous Pneumothorax
Clinically Stable Patients With Small Pneumothoraces:
Clinically stable patients with small pneumothoraces should be
hospitalized (good consensus). Patients should not be managed in the
emergency department with observation or simple aspiration without
hospitalization (very good consensus). Hospitalized patients may be
observed (good consensus) or treated with a chest tube (some
consensus), depending on the extent of their symptoms and the course of
their pneumothorax. Some of the panel members argued against
observation alone because of a report of deaths with this
approach.22
Patients should not be referred for
thoracoscopy without prior stabilization (very good consensus). The
presence of symptoms for > 24 h did not alter the panel members
recommendations.
Clinically Stable Patients With Large Pneumothoraces:
Clinically stable patients with large pneumothoraces should undergo the
placement of a chest tube to reexpand the lung and should be
hospitalized (very good consensus). Patients should not be referred for
thoracoscopy without prior stabilization with a chest tube (very good
consensus). The presence of symptoms for > 24 h did not alter the
panel members recommendations.
Clinically Unstable Patients With Pneumothoraces of Any Size:
Patients should undergo placement of a chest tube to reexpand the lung
and should be hospitalized (very good consensus). Patients should not
be referred for thoracoscopy without prior stabilization with a chest
tube (very good consensus).
Chest Tube Management:
The size of chest tubes used for patients with secondary pneumothoraces
depends on clinical circumstances.
Unstable patients (very good consensus) and patients who appear to be at risk for large pleural air leaks because they require mechanical ventilation (good consensus) should be managed with a 24F to 28F chest tube. Larger chest tubes were not considered necessary by the panel members (some consensus).
Stable patients who are not at risk for large air leaks should be
managed with 16F to 22F chest tubes (good consensus), although a
small-bore catheter (
14F) may be acceptable in certain
circumstances, which would include small pneumothoraces and patient
preference (good consensus). Some members of the panel were concerned
with the risk for occlusion of a small-bore catheter.
Attachment of the chest tube to a water seal device with (some consensus) or without (good consensus) suction is acceptable management for most patients. Patients treated with water seal alone should be managed with suction if the lung fails to reexpand (good consensus). A Heimlich valve (good consensus) may be used, although the panel considered a water seal device to be a better option for most patients.
Pneumothorax Recurrence Prevention:
Most members (81%) of the panel recommend an intervention to prevent
pneumothorax recurrence after the first occurrence because of the
potential lethality of secondary pneumothoraces.23
24
25
26
The
remaining 19% of panel members would perform an intervention to
prevent recurrence after the second spontaneous pneumothorax. The
preferred management for pneumothorax recurrence prevention is surgical
(very good consensus) because of the lower recurrence rates with these
interventions compared to the instillation of a sclerosing agent
through a chest tube.3
The instillation of a sclerosant
through a chest tube, however, may be used in certain circumstances
(good consensus) based on patients contraindications to surgery,
management preferences, or a poor prognosis from the patients
underlying disease.
Medical or surgical thoracoscopy is preferred management (very good consensus), although a muscle-sparing (axillary) thoracotomy is an acceptable alternative (good consensus). A standard thoracotomy through a lateral or median sternotomy approach is not appropriate therapy for most patients (good consensus).
Most members of the panel recommend bullectomy and a procedure to produce pleural symphysis during the surgical intervention. Staple bullectomy was the preferred procedure for bullectomy (very good consensus). Other methods for bullectomy were ranked as indeterminate to inappropriate, with levels of consensus that ranged from no consensus to good consensus. Acceptable interventions to produce pleural symphysis included parietal pleurectomy (some consensus), talc insufflation (poudrage) (some consensus), and parietal pleural abrasion (good consensus). Fibrin pleurodesis and intraoperative instillation of sclerosing agents other than talc were considered to be rarely acceptable (some consensus). Parietal pleurectomy or parietal pleural abrasion limited to the upper half of the hemithorax constitutes the preferred therapy for most patients (good consensus).
For producing pleural symphysis by instillation of a sclerosing agent through a chest tube, doxycycline (good consensus) and talc slurry (very good consensus) were the preferred agents. Minocycline was considered to be an acceptable alternative agent for some patients (good consensus), but bleomycin was considered rarely acceptable (good consensus).
Assessment of Pulmonary Function:
The performance of pulmonary function tests to assist management
decisions is considered inappropriate (perfect consensus) for patients
presenting with secondary pneumothoraces. Performing forced expiratory
maneuvers during the acute phase of a pneumothorax is ill-advised and
may produce inaccurate results.
Seventy-seven percent of the panel members indicated, however, that results from previously performed pulmonary function tests would assist patient selection for an intervention to prevent a pneumothorax recurrence in special circumstances (good consensus). Those circumstances include patients with relatively good pulmonary function with a strong desire to avoid a procedure to prevent a recurrence. Such patients would most likely tolerate another spontaneous pneumothorax with a low risk of death. Conversely, a patient with poor lung function who decides to avoid recurrence prevention should be counseled that such a decision would be ill-advised.
Persistent Air Leaks:
For patients with persistent air leaks who are selected for observation
with prolonged chest tube drainage because they initially refuse a
surgical procedure, the panel recommended continued observation for 5
days (median, 5 days; interquartile range, 4 to 7 days; middle 80%
range, 2 to 7 days) before encouraging the patient to accept a surgical
intervention. More prolonged delays may decrease the effectiveness of
thoracoscopy27
and increase the cost of
care.28
The recommendations for surgical interventions for
patients with prolonged air leaks are similar to those for recurrence
prevention (see above). The panel concluded that the instillation of
chemical agents through a chest tube to produce a pleural symphysis in
managing persistent air leaks was appropriate management for patients
who were not operative candidates (good consensus). If this technique
was used, doxycycline (good consensus) and talc (very good consensus)
were the preferred agents.
Chest Tube Removal:
For patients treated with a chest tube without referral for a surgical
intervention to prevent a recurrence, management decisions for removing
the chest tube are similar with a few exceptions to those for patients
with a primary pneumothorax.
Forty-one percent of panel members would never clamp a chest tube to
detect the presence of an air leak after reexpansion of the lung. The
remaining panel members would clamp the chest tube 5 to 12 h after
the last evidence of an air leak. Regardless of whether the tube was or
was not clamped, panel members would repeat a chest radiograph 13 to
23 h after the last evidence of an air leak (63% of members) to
ensure that the pneumothorax had not reoccurred in preparation for
pulling the chest tube. Other panel members would wait
4 h (4%), 5
to 12 h (18%), or 24 h (15%).
Chest Imaging With CT:
The panel could not develop recommendations for the use of chest CT
scanning after the first occurrence of a pneumothorax. Obtaining a
chest CT scan was considered acceptable management for patients with
pneumothorax recurrence (good consensus), during management of a
persistent air leak (some consensus), and for planning a surgical
intervention (some consensus). Chest CT scans might be especially
useful if lung volume reduction surgery was being considered as an
adjunctive procedure.
Age Considerations:
Ninety percent of the panel members did not incorporate the patients
age into the determination of management decisions.
| Comparison to Previous Guidelines |
|---|
|
|
|---|
Both the present ACCP and the BTS guidelines base treatment recommendations on the severity of symptoms and the degree of lung collapse, as determined by chest radiographs. Symptom assessments in the BTS guideline, however, are based only on the presence or absence of obvious deterioration in usual exercise tolerance (termed significant dyspnea). The BTS statement also uses a different method for grading the degree of lung collapse that includes levels of small (small rim of air around lung), moderate (lung collapsed halfway toward heart border), and complete pneumothorax (airless lung).
The BTS statement emphasizes the utility of observation without pleural drainage as initial management for patients without significant dyspnea who have (1) small or moderately sized primary pneumothoraces or (2) small secondary pneumothoraces. Simple aspiration with immediate catheter removal is the initial intervention recommended for the remaining patients. The placement of a chest tube with water-seal drainage without suction is recommended only for patients who fail simple aspiration. The present ACCP guideline consensus process found simple aspiration to be appropriate rarely in any clinical circumstance, although two panel members argued that simple aspiration is usually effective for stable patients.
In the BTS statement, hospitalization is recommended only for patients with secondary pneumothoraces. No specific recommendations are provided for patients with persistent air leaks or for patients who require surgery.
| Strengths and Limitations of the Guideline |
|---|
|
|
|---|
|
| Guideline Implementation and Consensus Data |
|---|
|
|
|---|
| Priorities for Future Research |
|---|
|
|
|---|
These issues call for prospective studies that have adequate sample sizes and follow-up periods to show effects. Study end points should include the relevant clinical outcomes, such as mortality, morbidity, patient perceptions, functional status, and cost.
| Appendix 1 |
|---|
|
|
|---|
Content Co-Chairman
Charlie Strange, MD, FCCP (Pulmonary), Associate Professor of
Medicine, Division of Pulmonary and Critical Care Medicine, Medical
University of South Carolina, Charleston, SC.
Methodology Chairman
John E. Heffner, MD, FCCP (Pulmonary), Professor of Medicine,
Associate Dean, Medical University of South Carolina, Charleston, SC.
Project Development Committee Members
Richard Light, MD, FCCP (Pulmonary), Professor of Medicine,
Vanderbilt University, Director, Pulmonary Diseases, Saint Thomas
Hospital, Nashville, TN; Steven A. Sahn, MD, FCCP (Pulmonary),
Professor of Medicine and Director, Division of Pulmonary and Critical
Care Medicine, Allergy and Clinical Immunology, Medical University of
South Carolina, Charleston, SC; Thomas J. Kirby, MD (Thoracic Surgery),
Co-Chairman and Professor of Surgery, Director, Thoracic Surgery,
University Hospitals of Cleveland, Cleveland, OH; Jeffrey Klein, MD,
FCCP (Interventional Radiology), Associate Professor and Vice Chairman,
Department of Radiology, University of Vermont College of Medicine,
Burlington, VT; James D. Luketich, MD (Thoracic Surgery), Assistant
Professor of Surgery, Section Head, Thoracic Surgery, Co-Director,
Minimally Invasive Surgery Center, Co-Director, Lung Cancer Center,
University of Pittsburgh Medical Center, Pittsburgh, PA; and Edward A.
Panacek, MD, FCCP (Emergency Medicine), Professor of Medicine,
Emergency Medicine Residency Director, University of California-Davis,
Sacramento, CA.
Expert Panel
Pulmonologist Participants:
Andrew C. Miller, MD, PhD, FCCP,
Consultant Physician, Mayday University Hospital, Croydon, UK; Colin
Selby, DM, Consultant Physician, Queen Margaret Hospital, Dunfermline,
Fife, UK; Ian Johnston, MD, Consultant Physician, University Hospital,
Queens Medical Center, Nottingham, UK; John Harvey, MD, Consultant
Respiratory Physician, Southmead Hospital, Bristol, UK; Marc Noppen,
MD, PhD, Head, Interventional Endoscopy Unit, Respiratory Division,
Academic Hospital AZ-VUB, Brussels, Belgium; F. M. N. H.
Schramel, MD, PhD, Department of Pulmonary Diseases, St. Antonius
Hospital, The Netherlands; and Harmeet S. Gill, MD, FCCP, Desert
Pulmonary Consultants, PLC, Desert Samaritan Regional Medical Center,
Mesa, AZ.
Surgeon Participants:
David Waller, FRCS (Cth), Consultant
Thoracic Surgeon, Glenfield Hospital, Leicester, UK; Richard
Berrisford, ChM (CTh), Consultant Thoracic Surgeon, Royal Devon and
Exeter NHS Trust, Exeter, UK; Anthony P. C. Yim, MD, FCCP, Chief,
Division of Cardiothoracic Surgery, Prince of Wales Hospital, The
Chinese University of Hong Kong, Satin, New Territories, Hong Kong;
Jose Ribas Milanez de Campos, MD, Associate Professor of Division of
Thoracic Surgery, Hospital Das Clinicas, University of Sao Paulo
Medical School, Sao Paulo, Brazil; Mark Ferguson, MD, FCCP, Professor,
Department of Surgery, The University of Chicago, Chicago, IL; Andrus
Votik, MD, MSc, PhD, Surgeon-in-Chief, The Salvation Army Scarborough
Grace Hospital, Scarborough, Ontario, Canada; Kerry Lynn Paape, MD,
Cardiovascular Institute of the South, Houma, LA; James E. Stephenson,
MD, Palmetto State Surgical Associates, Greenville Memorial
Hospital, Department of Surgery, Greenville, SC; Averel B. Snyder, MD,
Peachtree Cardiovascular and Thoracic Surgeons, PA, Atlanta, GA; Steven
M. Keller, MD, FCCP, Associate Professor, Chief of Thoracic Surgery,
Beth Israel Medical Center, New York, NY; and Rodney J. Landreneau, MD,
Professor of Surgery, Head, Division of General Thoracic Surgery,
Allegheny General Hospital Campus, Medical College of Pennsylvania,
Pittsburgh, PA.
Radiology Participants:
Edward F. Patz, Jr, MD, Professor of
Radiology, Department of Radiology, Duke University Medical Center,
Durham, NC; and Dewey Conces, MD, Professor of Radiology, Indiana
University Hospital, Indianapolis, IN.
Emergency Medicine Participants:
Kenneth Frumkin, PhD, MD,
Emergency Department, Chesapeake General Hospital, Chesapeake, VA;
Joseph Varon, MD, FCCP, Associate Professor of Medicine, Pulmonary and
Critical Care Section, Baylor College of Medicine, Research Director,
Emergency Services, The Methodist Hospital, Houston, TX; and Seth
Wright, MD, MPH, Associate Professor of Emergency Medicine, Department
of Emergency Medicine, Vanderbilt University, Nashville, TN.
Questionnaire Design Review:
Gerard Silvestri, MD, Associate
Professor of Medicine, Division of Pulmonary and Critical Care
Medicine, Medical University of South Carolina, Charleston, SC.
| Appendix 2 |
|---|
|
|
|---|
1-antitrypsin deficiency-induced emphysema
in nonsmokers with healed spontaneous pneumothorax, identified by
computed tomography of the lungs. Chest 1993; 103:433438 Bertrand P, Regnard J, Spaggiari L, et al. Immediate and long-term results after surgical treatment of primary spontaneous pneumothorax by VATS. Ann Thorac Surg 1996; 61:16411645
Campisi P, Voitk AJ. Outpatient treatment of spontaneous pneumothorax in a community hospital using a Heimlich flutter valve: a case series. J Emerg Med 1997; 15:115119
Cannon W, Mark J, Jamplis R. Pneumothorax: a therapeutic update. Am J Surg 1981; 142:2629
Conces DJ, Tarver RD, Gray WC, et al. Treatment of pneumothoraces utilizing small caliber chest tubes. Chest 1988; 94:5557
Gammie JS, Banks MC, Fuhrman CR, et al. The pigtail catheter for pleural drainage: a less invasive alternative to tube thoracostomy. JSLS (J Soc Laparoendosc Surg) 1999; 3:5761
Gobbel W. Spontaneous pneumothorax. J Thorac Cardiovasc Surg 1963; 46:331345
Graham A. Videothoracoscopy and spontaneous pneumothorax. Ann Thorac Surg 1995; 59:266267
Janssen J, Schramel F, Sutedja T, et al. Videothoracoscopic appearance of first and recurrent pneumothorax. Chest 1995; 108:330334
Jones J. A place for aspiration in the treatment of spontaneous pneumothorax. Thorax 1985; 40:6667
Kennedy L, Sahn SA. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 1994; 106:12151222
Lesur O, Delorme N, Fromaget J, et al. Computed tomography in the etiologic assessment of idiopathic spontaneous pneumothorax. Chest 1990; 98:341347
Liu H, Lin P, Hsieh M, et al. Thoracoscopic surgery as a routine procedure for spontaneous pneumothorax: results from 82 patients. Chest 1995; 107:559562
Luketich J, Kiss M, Hershey J, et al. Chest tube insertion: a prospective evaluation of pain management. Clin J Pain 1998; 14:152154
Massard G, Thomas P, Wihlm J. Minimally invasive management for first and recurrent pneumothorax. Ann Thorac Surg 1998; 66:592599
Mathur R, Cullen J, Kinnear WJM, et al. Time course of resolution of persistent air leak in spontaneous pneumothorax. Respir Med 1995; 89:129132
Mercier C, Page A, Verdant A, et al. Outpatient management of intercostal tube drainage in spontaneous pneumothorax. Ann Thorac Surg 1976; 22:163165
Milanez J, Vargas F, Filomeno L, et al. Intrapleural talc for the prevention of recurrent pneumothorax. Chest 1994:11621165
Minami H, Saka H, Senda K, et al. Small caliber catheter drainage for spontaneous pneumothorax. Am J Med Sci 1992; 304:345347
Mitlehner W, Friedrich M, Dissmann W. Value of computed tomography in the detection of bullae and blebs in patients with primary spontaneous pneumothorax. Respiration 1992; 59:221227
Naunheim K, Mack M, Hazelrigg S, et al. Safety and efficacy of video-assisted thoracic surgical techniques for the treatment of spontaneous pneumothorax. J Thorac Cardiovasc Surg 1995; 109:11981203
Ng AW, Chan KW, Lee SK. Simple aspiration of pneumothorax. Singapore Med J 1994; 35:5052
Nickoladze GD. Treatment of spontaneous pneumothorax with Heimlich flutter valve. J Thorac Cardiovasc Surg 1990; 99:757758
Noppen M, Meysman M, DHaese J, et al. Comparison of video-assisted thoracoscopic talcage for recurrent primary versus persistent secondary spontaneous pneumothorax. Eur Respir J 1997; 10:412416
Schoenenberger RA, Haefeli WE, Weiss P, et al. Timing of invasive procedures in therapy for primary and secondary spontaneous pneumothoraces. Arch Surg 1991; 126:764766
Schoenenberger R, Haefeli W, Weiss P, et al. Evaluation of conventional chest tube therapy for iatrogenic pneumothorax. Chest 1993; 104:17701772
Schramel F, Sutedja T, Braber J, et al. Cost-effectiveness of video-assisted thoracoscopic surgery versus conservative treatment for first time or recurrent spontaneous pneumothorax. Eur Respir J 1996; 9:18211885
Seaton D, Yoganathan K, Coady T, et al. Spontaneous pneumothorax: marker gas technique for predicting outcome of manual aspiration. BMJ 1991; 302:262265
Seremetis M. The management of spontaneous pneumothorax. Chest 1970; 57:6568
Sharma T, Agnihotri S, Jain N, et al. Intercostal tube thoracostomy in pneumothorax. Factors influencing re-expansion of lung. Indian J Chest Dis Allied Sci 1988; 30:3235
So S, Yu D. Catheter drainage of spontaneous pneumothorax: suction or no suction, early or late removal? Thorax 1982; 37:4648
Stradling P, Poole G. Conservative management of spontaneous pneumothorax. Thorax 1966; 21:145149
Van de Brekel J, Duurkens V, Vanderschueren R. Pneumothorax: results of thoracoscopy and pleurodesis with talc poudrage and thoracotomy. Chest 1993; 103:345347
Voge V, Anthracite R. Spontaneous pneumothorax in the USAF aircrew population: a retrospective study. Aviat Space Environ Med 1986; 57:939949
Wait MA, Estrera A. Changing clinical spectrum of spontaneous pneumothorax. Am J Surg 1992; 164:528531
Waller DA, Forty J, Morritt GN. Video-assisted thoracoscopic surgery versus thoracotomy for spontaneous pneumothorax. Ann Thorac Surg 1994; 58:372377
Waller D, Forty J, Soni A, et al. Videothoracoscopic operation for secondary spontaneous pneumothorax. Ann Thorac Surg 1994; 57:16121615
Warner B, Bailey W, Shipley T. Value of computed tomography of the lung in the management of primary spontaneous pneumothorax. Am J Surg 1991; 162:3942
Weeden D, Smith G. Surgical experience in the management of spontaneous pneumothorax. Thorax 1983; 38:737743
Yim A, Ho J, Lai C, et al. Primary spontaneous pneumothorax treated by video assisted thoracoscopic surgery-results of intermediate follow up. Aust N Z J Med 1995; 25:146150
Yim A. Video-assisted thoracoscopic suturing of apical bullae: an alternative to staple resection in the management of primary spontaneous pneumothorax. Surg Endosc 1995; 9:10131016
Yim A, Liu H. Video assisted thoracoscopic management of primary spontaneous pneumothorax. Surg Laparosc Endosc 1997; 7:236240
| Acknowledgements |
|---|
| Footnotes |
|---|
Additional information about the questionnaire, consensus tables, and other data are available at www.chestnet.org/publications/18098/index.html.
Received for publication June 2, 2000. Accepted for publication September 14, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. H. Baumann To Bleb or Not To Bleb? Chest, October 1, 2007; 132(4): 1110 - 1112. [Full Text] [PDF] |
||||
![]() |
A. Lal, G. Anderson, M. Cowen, S. Lindow, and A. G. Arnold Pneumothorax and Pregnancy Chest, September 1, 2007; 132(3): 1044 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Marcheix, L. Brouchet, C. Renaud, Y. Lamarche, A. Mugniot, V. Benouaich, J. Berjaud, and M. Dahan Videothoracoscopic silver nitrate pleurodesis for primary spontaneous pneumothorax: an alternative to pleurectomy and pleural abrasion? Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1106 - 1109. [Abstract] [Full Text] [PDF] |
||||